Browsing by Author Uzairu, Adamu

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
20242,4-disubstituted 6-fluoroquinolines as potent antiplasmodial agents: QSAR, homology modeling, molecular docking and ADMET studiesShallangwa, Gideon A.; Mahmud, Aliyu W.; Uzairu, Adamu; Ibrahim, Muhammad T.
2024Activity prediction, structure-based drug design, molecular docking, and pharmacokinetic studies of 1,4-dihydropyridines derivatives as aamylase inhibitorsAminu, Khalifa S.; Uzairu, Adamu; Abechi, Stephen E.; dkk.
2023Homology modeling, docking, and ADMET studies of benzoheterocyclic 4-aminoquinolines analogs as inhibitors of Plasmodium falciparumIbrahim, Zakari Y.; Uzairu, Adamu; Shallangwa, Gideon A.; dkk.
2023In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptorNulamuga, Benson; Uzairu, Adamu; Babalola, Ibrahim T.; Ibrahim, Muhammad T.; Umar, Abdullahi B.
2024Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studiesJa’afaru, Saudatu C.; Uzairu, Adamu; Chandra, Anshuman; dkk.
2023Molecular docking-based virtual screening, drug-likeness, and pharmacokinetic profiling of some anti-Salmonella typhimurium cephalosporin derivativesAmeji, Philip John; Uzairu, Adamu; Shallangwa, Gideon Adamu; Uba, Sani
2023New flavone-based arylamides as potential V600E-BRAF inhibitors: Molecular docking, DFT, and pharmacokinetic propertiesUmar, Abdullahi B.; Uzairu, Adamu
2023Obstructing Salmonella typhi’s virulence in eukaryotic cells through design of its SipB protein antagonistsAmeji, John P.; Uzairu, Adamu; Shallangwa, Gideon A.; Uba, Sani
2023Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agentsAbdullahi, Sagiru Hamza; Uzairu, Adamu; Shallangwa, Gideon Adamu; dkk.
2023Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinase inhibitorsUmar, Abdullahi B.; Uzairu, Adamu